(Reuters) – Moderna Inc said on Thursday that waiving intellectual property rights on COVID-19 vaccines will not help boost supply in 2021 or 2022, a day after U.S. President Joe Biden backed a proposed waiver that is aimed at giving poorer companies access.
(Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)
Pickleball to take over NYC: Billie Jean King National Tennis Center, Queens to host 2024 New York City Open in May
Not every WNBA draft pick will make her team’s roster. Here’s why
Michigan’s QB battle among many in Big Ten that started in spring and will ramp up again in the fall
French Open to reveal second retractable roof court at Roland Garros ahead of Olympics
Thibodeau shows when he’s mad at his Knicks. They don’t mind, knowing the coach has them set to win
8 years after the National Enquirer’s deal with Donald Trump, the iconic tabloid is limping badly
Salt & Straw ice cream pop-ups open today and tomorrow offering cool spring treats
A US citizen facing drug charges in Russia appears in court. His case was adjourned until mid-May
EU military officer says a frigate has destroyed a drone launched from Yemen’s Houthi-held areas
Here’s why Spain’s leader is mulling his future while denouncing a ‘smear campaign’ against his wife
UN report says 282 million people faced acute hunger in 2023, with the worst famine in Gaza
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
US births fell last year, marking an end to the late pandemic rebound, experts say
US abortion battle rages on with moves to repeal Arizona ban and a Supreme Court case
